Page last updated: 2024-09-02

n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine and Neoplasms

n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, M; Liu, Y; Song, T; Wei, X; Wu, C; Yang, G; Yang, H; Zhang, H; Zhou, W1

Other Studies

1 other study(ies) available for n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine and Neoplasms

ArticleYear
Stimulus-Detonated Biomimetic "Nanobomb" with Controlled Release of HSP90 Inhibitor to Disrupt Mitochondrial Function for Synergistic Gas and Photothermal Therapy.
    Advanced healthcare materials, 2023, Volume: 12, Issue:26

    Topics: Antineoplastic Agents; Biomimetics; Cell Line, Tumor; Delayed-Action Preparations; Humans; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy; Tumor Microenvironment

2023